Effects of a Novel Nutraceutical Combination (Aquilea Colesterol(®)) on the Lipid Profile and Inflammatory Biomarkers: A Randomized Control Trial

Background: Cholesterol-lowering nutraceuticals are useful in the management of moderate hypercholesterolemia. Methods: In a parallel-group, randomized, placebo-controlled double-blind trial we evaluated the effects on plasma total cholesterol, low-density lipoprotein cholesterol (LDL-c), and inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Domenech, Mònica, Casas, Rosa, Ruiz-León, Ana Maria, Sobrino, Javier, Ros, Emilio, Estruch, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566177/
https://www.ncbi.nlm.nih.gov/pubmed/31035469
http://dx.doi.org/10.3390/nu11050949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566177/
https://www.ncbi.nlm.nih.gov/pubmed/31035469
http://dx.doi.org/10.3390/nu11050949

Ejemplares similares